Trial intelligence / Profile preview

Tamiflu in immune thrombocytopenic purpura

ChiCTR-ONRC-13004109Phase 4Completed

Sponsor
First Affiliated Hospital of Soochow University
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of oseltamivir in immune thrombocytopenia (ITP) (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Platelet count. Started Dec 2013; status: completed.

02

Drugs

oseltamivir
03

Conditions

immune thrombocytopenia (ITP)

Beyond the preview

Go deeper on ChiCTR-ONRC-13004109.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-ONRC-13004109.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call